[india-drug] Response to use of anti retroviral drugs in India

["Dr. Dandiya" <dandiya@sancharnet.in>]

Response to use of anti retroviral drugs in India
-------------------------------------------------------

Dear Dr. Roy Chaudhury,

In response to "Use of ARVs in India", it is suggested that the well
established treatment schedules / Standard treatment protocols be 
offered at selected Institutional levels (rather than home based)
having adequate facilities to monitor the viral load (PCR) and CD4
counts supported by expert services, especially that of dermatology,
gastroenterology and neurology in order to ensure safety and
compliance. DOTS strategy may not be successful, as patient would
expect a high degree of confidentiality in availing the treatment for
HIV. In the first phase the Medical colleges be considered for
initiation and continuation of ARV treatment until required laboratory
and expert services support is established at district level.

NK Gurbani
Secretary, 
Rajasthan Society for Promotion of Rational Use of Drugs (RSPRUD)

PC Dandiya
President, RSPRUD


________________________________________________________________________
Yahoo! India Mobile: Download the latest polyphonic ringtones.
Go to http://in.mobile.yahoo.com

Access Essential Drugs Monitor #32 at http://www.who.int/medicines/mon/mon32.shtml

The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@healthnet.org